Quantum Biopharma Ltd. Files 6-K Report
Ticker: QNTM · Form: 6-K · Filed: May 29, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | May 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, 6-K
TL;DR
Quantum Biopharma (fka FSD Pharma) filed a routine 6-K report on 5/29/25. Nothing major, just compliance.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on May 29, 2025. The company, incorporated in A6 with its fiscal year ending December 31, is headquartered in Toronto, Canada. This filing is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates ongoing reporting obligations for Quantum Biopharma Ltd. as a foreign private issuer, providing transparency to investors regarding its regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a standard regulatory report and does not contain new financial information or significant operational updates.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the 6-K report
- FSD Pharma Inc. (company) — Former name of Quantum Biopharma Ltd.
- May 29, 2025 (date) — Filing date of the 6-K report
- Toronto, Ontario (location) — Location of the company's principal executive office
- 001-39152 (other) — Commission File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K filing is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the company makes or is required to make public in its home country, files with a stock exchange, or distributes to its security holders.
When was Quantum Biopharma Ltd. formerly known as?
Quantum Biopharma Ltd. was formerly known as FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd. headquartered?
Quantum Biopharma Ltd.'s principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Does Quantum Biopharma Ltd. file annual reports under Form 20-F or 40-F?
Quantum Biopharma Ltd. indicates it files annual reports under cover of Form 20-F.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 29, 2025 regarding Quantum Biopharma Ltd. (QNTM).